Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renin-angiotensin system and progression of chronic liver diseases.

Literature DB >> 17096072

Renin-angiotensin system and progression of chronic liver diseases.

Hitoshi Yoshiji, Hiroshi Fukui.

Abstract

Entities: Chemical

Mesh：

Year: 2006 PMID： 17096072 DOI： 10.1007/s00535-006-1897-8

Source DB: PubMed Journal: J Gastroenterol ISSN： 0944-1174 Impact factor: 6.772

× No keyword cloud information.

35 in total

1. Angiotensin II induces contraction and proliferation of human hepatic stellate cells.

Authors: R Bataller; P Ginès; J M Nicolás; M N Görbig; E Garcia-Ramallo; X Gasull; J Bosch; V Arroyo; J Rodés
Journal: Gastroenterology Date: 2000-06 Impact factor: 22.682

2. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis.

Authors: A Helmy; R Jalan; D E Newby; P C Hayes; D J Webb
Journal: Gastroenterology Date: 2000-03 Impact factor: 22.682

3. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

Authors: Yuki Terui; Takafumi Saito; Hisayoshi Watanabe; Hitoshi Togashi; Sumio Kawata; Yoshihiro Kamada; Shigeru Sakuta
Journal: Hepatology Date: 2002-10 Impact factor: 17.425

4. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.

Authors: J R Jonsson; A D Clouston; Y Ando; L I Kelemen; M J Horn; M D Adamson; D M Purdie; E E Powell
Journal: Gastroenterology Date: 2001-07 Impact factor: 22.682

5. Host genetic factors influence disease progression in chronic hepatitis C.

Authors: E E Powell; C J Edwards-Smith; J L Hay; A D Clouston; D H Crawford; C Shorthouse; D M Purdie; J R Jonsson
Journal: Hepatology Date: 2000-04 Impact factor: 17.425

6. Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats.

Authors: T Ohishi; H Saito; K Tsusaka; K Toda; H Inagaki; Y Hamada; N Kumagai; K Atsukawa; H Ishii
Journal: Hepatol Res Date: 2001-10 Impact factor: 4.288

Review 7. Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy.

Authors: Hitoshi Yoshiji; Shigeki Kuriyama; Ryuichi Noguchi; Hiroshi Fukui
Journal: Curr Cancer Drug Targets Date: 2004-11 Impact factor: 3.428

8. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.

Authors: H Yoshiji; S Kuriyama; J Yoshii; Y Ikenaka; R Noguchi; D J Hicklin; Y Wu; K Yanase; T Namisaki; M Yamazaki; H Tsujinoue; H Imazu; T Masaki; H Fukui
Journal: Gut Date: 2003-09 Impact factor: 23.059

9. Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

Authors: Ryuichi Noguchi; Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Yasuhide Ikenaka; Koji Yanase; Tadashi Namisaki; Mitsuteru Kitade; Masaharu Yamazaki; Akira Mitoro; Hirohisa Tsujinoue; Hiroo Imazu; Tsutomu Masaki; Hiroshi Fukui
Journal: Clin Cancer Res Date: 2003-12-01 Impact factor: 12.531

10. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.

Authors: Antoni Rimola; María-Carlota Londoño; Gonzalo Guevara; Miquel Bruguera; Miquel Navasa; Xavier Forns; Montserrat García-Retortillo; Juan-Carlos García-Valdecasas; Juan Rodes
Journal: Transplantation Date: 2004-09-15 Impact factor: 4.939

4 in total

4. Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out Mice.

Authors: Kaliappan Gopal; Munusamy Gowtham; Singh Sachin; Mani Ravishankar Ram; Esaki M Shankar; Tunku Kamarul
Journal: Sci Rep Date: 2015-12-16 Impact factor: 4.379